(Q43147233)

14 November 2017

title

Verapamil attenuates the malignant treatment course in recurrent status epilepticus (English)

1 reference

14 November 2017

1 reference

1 reference

Friedhelm C Schmitt

1

1 reference

14 November 2017

Christoph Dehnicke

series ordinal

2

1 reference

14 November 2017

Martin Merschhemke

series ordinal

3

1 reference

14 November 2017

Heinz-Joachim Meencke

series ordinal

4

1 reference

14 November 2017

language of work or name

1 reference

1 March 2010

1 reference

14 November 2017

1 reference

14 November 2017

volume

17

1 reference

14 November 2017

issue

4

1 reference

14 November 2017

page(s)

565-568

1 reference

The anaesthetic and intensive care of status epilepticus

14 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.01.166

The neurobiology of antiepileptic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.01.166

Mechanistic and pharmacologic aspects of status epilepticus and its treatment with new antiepileptic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.01.166

A "malignant" variant of status epilepticus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.01.166

Mechanisms of drug resistance in status epilepticus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.01.166

Potential role of drug transporters in the pathogenesis of medically intractable epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.01.166

Modulation of P-glycoprotein at the blood-brain barrier: opportunities to improve central nervous system pharmacotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.01.166

Several major antiepileptic drugs are substrates for human P-glycoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.01.166

Refractory status epilepticus: effect of treatment aggressiveness on prognosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.01.166

A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.01.166

Electrocardiographic abnormalities in patients with cluster headache on verapamil therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.01.166

Risk of unprovoked seizure after acute symptomatic seizure: effect of status epilepticus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.01.166

A systematic review of the epidemiology of status epilepticus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.01.166

Recurrent status epilepticus in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.01.166

Use of verapamil as a potential P-glycoprotein inhibitor in a patient with refractory epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.01.166

Calcium-channel blocker verapamil administration in prolonged and refractory status epilepticus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.01.166

Addition of verapamil in the treatment of severe myoclonic epilepsy in infancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.01.166

Calcium channel blockers verapamil and nimodipine inhibit kindling in adult and immature rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.01.166

Anticonvulsant effects of some calcium entry blockers in DBA/2 mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.01.166

10.1016/J.YEBEH.2010.01.166

7 January 2021

Identifiers

DOI

1 reference

14 November 2017

1 reference